You might be surprised at what I know!
As for "what ifs" I think the "what if APDN goes in for another round of destructive dilution" is probably a more likely hypothetical than the pharma-phantasy.
FYI You may want to take a hard look at the total amount of funding for R&D - which the company characterizes as "essential to our future success".
Less than $3 million in 2 years!
Averaging less than $1,5 million per year?!?
"We believe that our continued development of new and enhanced technologies relating to our core business is essential to our future success. We incurred approximately $1.6 million and $1.3 million on research and development activities for the fiscal years ended September 30, 2015 and 2014, respectively."
Feel free to get back to me with an example of a "high-tech" company in an intensely competitive industry that has found success with a $1,5mm R&D budget.
GL!